Stroke is one of the most common causes of morbidity and mortality worldwide. Despite significant advances in acute treatment and secondary prevention, primary prevention remains crucial to prevent the first occurrence of stroke and its serious consequences. The “Guideline for the Primary Prevention of Stroke” of the American Heart Association (AHA) and American Stroke Association (ASA) was fundamentally revised in 2024, replacing the previous recommendations from 2014.
Autoren
- Tanja Schliebe
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Acute nonspecific back pain
Implementing a biopsychosocial approach
- Psychedelic-assisted therapy
Current status of PAT
- Neuropathic Pain
Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Juvenile Idiopathic Arthritis
Early Detection and Targeted Treatment in an Interdisciplinary Setting
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Chronic hand eczema: common, long-lasting, and distressing
Non-steroidal anti-inflammatory treatment options are essential for long-term management
- Disorders of the Gut-Brain Interaction